These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. Ma Y; Katiyar P; Jones LP; Fan S; Zhang Y; Furth PA; Rosen EM Mol Endocrinol; 2006 Jan; 20(1):14-34. PubMed ID: 16109739 [TBL] [Abstract][Full Text] [Related]
43. A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer. Buckley NE; Haddock P; De Matos Simoes R; Parkes E; Irwin G; Emmert-Streib F; McQuaid S; Kennedy R; Mullan P Oncotarget; 2016 Apr; 7(15):19884-96. PubMed ID: 26943587 [TBL] [Abstract][Full Text] [Related]
44. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity. Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966 [TBL] [Abstract][Full Text] [Related]
45. A role for Id proteins in mammary gland physiology and tumorigenesis. de Candia P; Benera R; Solit DB Adv Cancer Res; 2004; 92():81-94. PubMed ID: 15530557 [TBL] [Abstract][Full Text] [Related]
46. The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer. Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Gruvberger-Saal SK; Saal LH; Holm K; Hegardt C; Arason A; Fagerholm R; Persson C; Grabau D; Johnsson E; Lövgren K; Magnusson L; Heikkilä P; Agnarsson BA; Johannsson OT; Malmström P; Fernö M; Olsson H; Loman N; Nevanlinna H; Barkardottir RB; Borg Å Cancer Res; 2012 Aug; 72(16):4028-36. PubMed ID: 22706203 [TBL] [Abstract][Full Text] [Related]
47. Can we prevent BRCA1-associated breast cancer by RANKL inhibition? Kotsopoulos J; Singer C; Narod SA Breast Cancer Res Treat; 2017 Jan; 161(1):11-16. PubMed ID: 27783278 [TBL] [Abstract][Full Text] [Related]
48. Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer. Liu X; Holstege H; van der Gulden H; Treur-Mulder M; Zevenhoven J; Velds A; Kerkhoven RM; van Vliet MH; Wessels LF; Peterse JL; Berns A; Jonkers J Proc Natl Acad Sci U S A; 2007 Jul; 104(29):12111-6. PubMed ID: 17626182 [TBL] [Abstract][Full Text] [Related]
52. c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression. Cantrell MA; Ebelt ND; Pfefferle AD; Perou CM; Van Den Berg CL Oncotarget; 2015 May; 6(14):11863-81. PubMed ID: 25970777 [TBL] [Abstract][Full Text] [Related]
53. Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer. Korlimarla A; Prabhu JS; Remacle J; Rajarajan S; Raja U; C E A; Srinath BS; Manjunath S; K S G; Correa M; M S N P; Sridhar TS PLoS One; 2016; 11(4):e0153113. PubMed ID: 27077368 [TBL] [Abstract][Full Text] [Related]
54. Activation of estrogen signaling pathways collaborates with loss of Brca1 to promote development of ERalpha-negative and ERalpha-positive mammary preneoplasia and cancer. Jones LP; Tilli MT; Assefnia S; Torre K; Halama ED; Parrish A; Rosen EM; Furth PA Oncogene; 2008 Jan; 27(6):794-802. PubMed ID: 17653086 [TBL] [Abstract][Full Text] [Related]
55. Increased progesterone receptor expression in benign epithelium of BRCA1-related breast cancers. King TA; Gemignani ML; Li W; Giri DD; Panageas KS; Bogomolniy F; Arroyo C; Olvera N; Robson ME; Offit K; Borgen PI; Boyd J Cancer Res; 2004 Aug; 64(15):5051-3. PubMed ID: 15289302 [TBL] [Abstract][Full Text] [Related]
56. [Promoter methylation of ID4. A marker for recurrence-free survival in human breast cancer]. Noetzel E; Veeck J; Horn F; Hartmann A; Knüchel R; Dahl E Pathologe; 2008 Nov; 29 Suppl 2():319-27. PubMed ID: 18807039 [TBL] [Abstract][Full Text] [Related]
57. Prepubertal octylphenol exposure up-regulate BRCA1 expression, down-regulate ERalpha expression and reduce rat mammary tumorigenesis. Peng JH; Zhang F; Zhang HX; Fan HY Cancer Epidemiol; 2009 Jul; 33(1):51-5. PubMed ID: 19679048 [TBL] [Abstract][Full Text] [Related]
58. Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer. Wu Q; Hoffmann MJ; Hartmann FH; Schulz WA Mol Cancer; 2005 May; 4(1):16. PubMed ID: 15876350 [TBL] [Abstract][Full Text] [Related]
59. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer. Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205 [TBL] [Abstract][Full Text] [Related]
60. The helix-loop-helix transcriptional regulator Id4 is required for terminal differentiation of luminal epithelial cells in the prostate. Hewa Bostanthirige D; Komaragiri SK; Joshi JB; Alzahrani M; Saini I; Jain S; Bowen NJ; Havrda MC; Chaudhary J Oncoscience; 2021; 8():14-30. PubMed ID: 33884281 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]